Rasmus is a globally recognised expert on scientific information and knowledge dissemination. He spent his earlier career as a Fortune500 strategist. Rasmus is a strong believer in the power of accurate information and new ideas - he founded his first, short lived, newspaper at the age of 13 - a passion that drove him to found Airfinity. As CEO of Airfinity he is often quoted in leading media companies such as Financial times, Bloomberg and CNN. He is a board member of the newspaper group, Information.dk. Rasmus holds a B.Sc. in Political Science, a MPA from Harvard University and is a recipient of the Crown Prince Frederic award for excellent scholarship. He lives in London.
Sacha is a digital media and ad-tech entrepreneur. He began his career by co-founding Ad pepper Media (IPO) in 1999. Since then, Sacha has advised and invested in numerous ventures and co-founded AdBrain, Scala Ventures, and Ogmenta. Applying his 20+ years’ experience, he is pioneering the use of technologies from ad-tech and media, such as semantic analysis, NLP and standardised metrics, to science information.
Henrik Sillesen is currently Professor and Head of Vascular Surgery at Rigshospitalet, University of Copenhagen, one of the largest vascular departments in Europe. Henrik Sillesen has published 215 peer-reviewed papers (PubMed) and has been cited over 9,700 times (H-index 42), giving 250+ lectures at international meetings in 34 countries. Henrik served as President of the European Society for Vascular Surgery (ESVS) from 2018-9, served as secretary general for ESVS in 2004-9, was the president of the Danish Heart Foundation across 2004-8, the President of the World Federation of Vascular Specialities between 2009-10 and the President of the Danish Vascular Society from 2002-4.
Claus Henrik Johansen is a highly experienced Life Science investor. He has been with Danske Bank Asset Management as a Senior Portfolio Manager since 2002 and has more than 16 years of experience investing within the Life Science industry. Claus participates in many global investor conferences and medical conferences in both US and Europe, and holds solid experience within both the healthcare and pharmaceutical value chain.
Arsalan is a former Victor Dahdaleh Fellow in the Department of Medicine at the University of Cambridge. He has an MSc from the University of Oxford in Molecular Oncology and a PhD in Cell Biology from Jesus College at the University of Cambridge. Arsalan has published several high-impact factor publications including in Nature and Small, with his most recent first author publication receiving attention in 110+ news outlets. He is also co-founder of two start-ups, SAANethical and PolicyBench.
Bhaskar is the lead analyst within cardio-metabolics. He is a Rhodes Scholar and a former Novo Nordisk STAR Research Fellow at the Department of Organic Chemistry and the Wellcome Centre for Human Genetics at the University of Oxford. Bhaskar has over 10 years' experience in developing drugs to study the biology of diabetes, cardiovascular disease and the epigenetic response. His research has resulted in departmental and university-level awards as well as publications in high impact factor journals. He holds a PhD from Oxford University.
Caroline heads up the Covid-19 team with a degree in Pharmacology from the University of Cambridge. Caroline has multiple years of experience in consulting in the pharmaceutical area and has worked with many of the industry's largest companies. At Airfinity, she has played a key role in building up the firm’s Covid-19 coverage and advises governments, investment funds and multi-nationals.
Jyothi has over 13 years of software development experience in designing, developing and implementing various applications including backend systems, data engineering, text/data mining and NLP pipelines in bioinformatics, academics and internet security. She previously worked for 9 years at the European Bioinformatics Institute in the UK. She holds an MCA (Master of Computer Applications) degree from India and enjoys developing NLP models in her spare time.
Louis has more than 8 years’ experience and wide-ranging exposure to the life science sector. He previously held a senior role at IQVIA where he managed and delivered challenging, multifaceted projects for a variety of healthcare clients, ranging in topics from therapy area deep dives, forecasting, product lifecycle management and competitor benchmarking. He completed his PhD in Structural Biology at Imperial College London and UCL, in collaboration with AstraZeneca.
Matt works in the infectious diseases team on forecasting and predictive models. He holds a PhD from the University of Cambridge, where he researched cellular interactions and bioactivity of medical materials. During his doctoral studies, Matt presented his research at international conferences, published a peer-reviewed paper and also patented the technology that he developed. Prior to his PhD, Matt achieved a 1st Class Honours Degree in Biotechnology and Bioengineering.
Simon has substantial experience in data and systems architecture, gained through working with small, medium, and large organisations as a data scientist and consulting engineer in diverse fields, including the telecommunications, nuclear, and space industries. He holds an MSc (Dist.) in Modern Communication Technologies with Business Management from the University of Sussex, an NZCE in Electronics Engineering, is a former military officer and member of the IET and IEEE. Simon has had one conference paper published as first author, in the field of medical imaging.